drugset / Trial / NCT00416546

Safety of AEB071 in Healthy Volunteers and to Compare the Ethnicity, Metabolic, and Safety Effects Between Caucasian and Japanese Healthy Subjects

NCT00416546

Phase 1 Completed 96 enrolled Novartis
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a study to assess the safety effects after multiple doses of AEB071 in healthy volunteers and to compare the ethnicity, metabolic, and safety effects between Caucasian and Japanese healthy subjects receiving single and multiple doses of AEB071.

Timeline

Start
2006-10
Primary completion
Completion
2007-10

Drugs

EvaluationDrugModalityDoseRoute
Subject sotrastaurin Small molecule

Indications

No indication recorded.